Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'aspartate' OR with Authors including 'aspartate' OR with Abstract including 'aspartate' OR with Keywords including 'aspartate'

Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Freedman DX LSD, Psychotogenic Procedures, and Brain Neurohumors. Psychopharmacol Bull 1975
Johnson M, Hanson GR, Gib... Effect of MK-801 on the decrease in tryptophan hydroxylase induced by ... Eur J Pharmacol 1989
Olney JW, Labruyere J, Pr... Pathological changes induced in cerebrocortical neurons by phencyclidi... Science 1989
Walker FO, Hunt VP An open label trial of dextromethorphan in Huntington's disease Clin Neuropharmacol 1989
Finnegan KT, Skratt JJ, I... The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prev... Neurosci Lett 1990
Johnson M, Bush LG, Gibb ... Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in n... Eur J Pharmacol 1991
Olney JW, Labruyere J, Wa... NMDA antagonist neurotoxicity: mechanism and prevention Science 1991
Farfel GM, Vosmer GL, Sei... The N-methyl-D-aspartate antagonist MK-801 protects against serotonin ... Brain Res 1992
Nash JF, Yamamoto BK Methamphetamine neurotoxicity and striatal glutamate release: comparis... Brain Res 1992
Sosnowski M Pain management: physiopathology, future research and endpoints Support Care Cancer 1993
Finnegan KT, Calder L, Cl... Effects of L-type calcium channel antagonists on the serotonin-depleti... Brain Res 1993
Rossner S, Schliebs R, Bi... Ibotenic acid lesion of nucleus basalis magnocellularis differentially... Brain Res 1994
Farfel GM, Seiden LS Role of hypothermia in the mechanism of protection against serotonergi... J Pharmacol Exp Ther 1995
Williams A, Unwin R Prolonged elevation of serum creatine kinase (CK) without renal failur... Nephrol Dial Transpl... 1997
Fitzal S [Ketamine and neuroprotection. Clinical outlook] Anaesthesist 1997
Nikolajsen L, Hansen PO, ... Oral ketamine therapy in the treatment of postamputation stump pain Acta Anaesthesiol Sc... 1997
Nelson KA, Park KM, Robin... High-dose oral dextromethorphan versus placebo in painful diabetic neu... Neurology 1997
Pereira SP, McCarthy M, E... Auxiliary partial orthotopic liver transplantation for acute liver fai... J Hepatol 1997
Lindefors N, Barati S, O'... Differential effects of single and repeated ketamine administration on... Brain Res 1997
Colado MI, Granados R, O'... Role of hyperthermia in the protective action of clomethiazole against... Br J Pharmacol 1998
Jones HE, Li H, Balster R... Failure of ibogaine to produce phencyclidine-like discriminative stimu... Pharmacol Biochem Be... 1998
Plesan A, Hedman U, Xu XJ... Comparison of ketamine and dextromethorphan in potentiating the antino... Anesth Analg 1998
Shen M, Thayer SA Cannabinoid receptor agonists protect cultured rat hippocampal neurons... Mol Pharmacol 1998
de Bruin NM, Ellenbroek B... Differential effects of ketamine on gating of auditory evoked potentia... Psychopharmacology B... 1999
Kolesnikov YA, Pasternak ... Peripheral blockade of topical morphine tolerance by ketamine Eur J Pharmacol 1999
Arvanov VL, Liang X, Russ... LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA recepto... Eur J Neurosci 1999
Berman RM, Cappiello A, A... Antidepressant effects of ketamine in depressed patients Biol Psychiatry 2000
Weinbroum AA, Rudick V, P... The role of dextromethorphan in pain control Can J Anaesth 2000
Shirayama Y, Hashimoto K,... 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA i... Eur J Pharmacol 2000
Escher M, Desmeules J, Gi... Hepatitis associated with Kava, a herbal remedy for anxiety BMJ 2001
Kraft M, Spahn TW, Menzel... [Fulminant liver failure after administration of the herbal antidepres... Dtsch Med Wochenschr 2001
Russell BR, Laverty R The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-in... Pharmacology, Bioche... 2001
Reneman L, Majoie CBLM, S... Pre-frontal N-acetylaspartate is strongly associated with memory perfo... Biological Psychiatr... 2001
Colado MI, Camarero J, Me... A study of the mechanisms involved in the neurotoxic action of 3,4- me... Br J Pharmacol 2001
Vollenweider FX, Geyer MA A systems model of altered consciousness: integrating natural and drug... Brain Res Bull 2001
Krupitsky EM, Burakov AM,... Attenuation of ketamine effects by nimodipine pretreatment in recoveri... Neuropsychopharmacol... 2001
Vollenweider FX Brain mechanisms of hallucinogens and entactogens Dialogues Clin Neuro... 2001
Campo JV, McNabb J, Perel... Kava-induced fulminant hepatic failure J Am Acad Child Adol... 2002
Reneman L, Majoie CB, Fli... Reduced N-acetylaspartate levels in the frontal cortex of 3,4- methyle... AJNR Am J Neuroradio... 2002
Smith KM, Larive LL, Roma... Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hyd... Am J Health Syst Pha... 2002
Gandolfi O, Gaggi R, Volt... The activation of serotonin receptors prevents glutamate-induced neuro... Pharmacol Res 2002
Umbricht D, Vollenweider ... Effects of the 5-HT(2A) Agonist Psilocybin on Mismatch Negativity Gene... Neuropsychopharmacol... 2002
Lim DK Ketamine associated psychedelic effects and dependence Singapore Med J 2003
Passie T, Karst M, Borsut... Effects of different subanaesthetic doses of (S)-ketamine on psychopat... J Psychopharmacol 2003
Dinse HR, Ragert P, Plege... Pharmacological modulation of perceptual learning and associated corti... Science 2003
Darlington CL Dexanabinol: A novel cannabinoid with neuroprotective properties IDrugs 2003
Moyano S, Frechilla D, De... NMDA receptor subunit and CaMKII changes in rat hippocampus induced by... Psychopharmacology (... 2004
Daumann J, Fischermann T,... Proton magnetic resonance spectroscopy in ecstasy (MDMA) users Neurosci Lett 2004
Kukanich B, Papich MG Plasma profile and pharmacokinetics of dextromethorphan after intraven... J Vet Pharmacol Ther 2004
Chen SL, Huang EY, Chow L... Dextromethorphan differentially affects opioid antinociception in rats Br J Pharmacol 2005
Grasshoff C, Gillessen T,... Ketamine reduces cholinergic modulated GABA release from rat striatal ... Toxicol Lett 2005
Ostroff R, Gonzales M, Sa... Antidepressant Effect of Ketamine During ECT Am J Psychiatry 2005
Narendran R, Frankle WG, ... Altered Prefrontal Dopaminergic Function in Chronic Recreational Ketam... Am J Psychiatry 2005
Tang Y, Zou H, Strong JA,... Paradoxical effects of very low dose MK-801 Eur J Pharmacol 2006
Zarate CA, Singh JB, Carl... A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-... Arch Gen Psychiatry 2006
de Win MM, Reneman L, Jag... A Prospective Cohort Study on Sustained Effects of Low-Dose Ecstasy Us... Neuropsychopharmacol... 2006
Carliss RD, Radovsky A, C... Oral administration of dextromethorphan does not produce neuronal vacu... Neurotoxicology 2007
Maeng S, Zarate CA, Du J,... Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine:... Biol Psychiatry 2007
Deakin JF, Lees J, McKie ... Glutamate and the neural basis of the subjective effects of ketamine: ... Arch Gen Psychiatry 2008
Stefanovic A, Brandner B,... Acute and chronic effects of ketamine on semantic priming: modeling sc... J Clin Psychopharmac... 2009
Dinis-Oliveira RJ, Carval... Suicide by hanging under the influence of ketamine and ethanol Forensic Sci Int 2010
Niciu MJ, Grunschel BD, C... Two cases of delayed-onset suicidal ideation, dysphoria and anxiety af... J Psychopharmacol 2013
Sanacora G, Smith MA, Pat... Lanicemine: a low-trapping NMDA channel blocker produces sustained ant... Mol Psychiatry 2013
Benzer TI, Nejad SH, Floo... Case records of the Massachusetts General Hospital Case 40-2013A 36-ye... N Engl J Med 2013
Lally N, Nugent AC, Lucke... Anti-anhedonic effect of ketamine and its neural correlates in treatme... Transl Psychiatry 2014
McLaughlin G, Morris N, K... Test purchase, synthesis, and characterization of 2-methoxydiphenidine... Drug Test Anal 2015
Zorumski CF, Nagele P, Me... Treatment-Resistant Major Depression: Rationale for NMDA Receptors as ... Front Psychiatry 2015
Litjens RP, Brunt TM How toxic is ibogaine? Clin Toxicol (Phila) 2016
Das RK, Tamman A, Nikolov... Nitrous oxide speeds the reduction of distressing intrusive memories i... Psychol Med 2016
Wallach J, Kang H, Colest... Pharmacological Investigations of the Dissociative 'Legal Highs' Diphe... PLoS One 2016
Kang H, Park P, Bortolott... Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor ... Neuropharmacology 2017
Williams NR, Heifets BD, ... Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor A... Am J Psychiatry 2018
Botanas CJ, de la Peņa JB... Methoxetamine: A foe or friend? Neurochem Int 2019
Martial C, Cassol H, Char... Neurochemical models of near-death experiences: a large-scale study ba... Conscious Cogn 2019
Zhang K, Hashimoto K Lack of Opioid System in the Antidepressant Actions of Ketamine Biol Psychiatry 2019